Chemoinformaics analysis of 3,4-Dihydroxyphenyl acetic acid
| Molecular Weight | 168.148 | nRot | 2 |
| Heavy Atom Molecular Weight | 160.084 | nRig | 7 |
| Exact Molecular Weight | 168.042 | nRing | 1 |
| Solubility: LogS | 0.037 | nHRing | 0 |
| Solubility: LogP | 0.563 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 21.9023 |
| nHD | 3 | BPOL | 8.89366 |
| QED | 0.569 |
| Synth | 1.838 |
| Natural Product Likeliness | 0.715 |
| NR-PPAR-gamma | 0.944 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.006 |
| HIA | 0.041 |
| CACO-2 | -5.317 |
| MDCK | 0.0000184 |
| BBB | 0.071 |
| PPB | 0.584599 |
| VDSS | 0.337 |
| FU | 0.336374 |
| CYP1A2-inh | 0.029 |
| CYP1A2-sub | 0.084 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.052 |
| CYP2c9-sub | 0.853 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.235 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.073 |
| CL | 17.407 |
| T12 | 0.94 |
| hERG | 0.012 |
| Ames | 0.638 |
| ROA | 0.103 |
| SkinSen | 0.801 |
| Carcinogencity | 0.17 |
| EI | 0.964 |
| Respiratory | 0.1 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.869173 |